55
Participants
Start Date
July 31, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
November 30, 2009
CPP-109 vigabatrin
tablets, bid for 12 weeks
Matching Placebo
tablets, bid, 12 weeks
North County Clinical Research (NCCR), Oceanside
South Bay Treatment Center, San Diego
Addiction Pharmacology Research Laboratory, St. Luke's Hospital, San Francisco
START Research and Treatment, Kansas City
Creighton University Medical Center, Omaha
Behavioral Health Research Center of the Southwest, Albuquerque
Pahl Pharmaceutical Research, Oklahoma City
Pillar Research, Dallas
Lead Sponsor
Catalyst Pharmaceuticals, Inc.
INDUSTRY